Health policy
0
elg_pic_full.jpg

Current Position: Vascular Surgery Integrated Resident at Stanford 

Elizabeth has interests in identifying high-value surgical care, the impact of frailty on surgical outcomes, gender and racial/ethnic disparities in access to and outcomes following vascular surgery, and the epidemiology and evolution of surgical vascular disease in the United States

MD, MS, Health Policy
Authors
Noa Ronkin
News Type
News
Date
Paragraphs

We are delighted to share that Young Kyung Do, APARC’s inaugural postdoctoral fellow in Asia health policy (2008-9), has won the 2020 Rothman Epidemiology Prize. The prize is awarded annually for the best paper published in the journal Epidemiology in the preceding year. Dr. Do is a professor in the Department of Health Policy and Management and director of the Institute of Health Policy and Management at the Seoul National University College of Medicine.

Dr. Do’s winning paper, titled “Causal Effect of Sleep Duration on Body Weight in Adolescents: A Population-based Study Using a Natural Experiment,” appeared in the November 2019 issue of Epidemiology. It provides new, population-level, causal evidence that corroborates consistent findings in the epidemiologic literature on the relationship between reduced sleep and increased body weight, particularly in children and adolescents.

Dr. Do’s study uses a unique natural experiment that arguably increased the sleep duration of adolescents in South Korea, where authorities in three of the 16 administrative regions required private tutoring institutes to close at 10 PM instead of later at night. This policy change was associated with sleep gain and body weight reduction in a subset of high school students whose sleep duration would otherwise have not increased. The natural experiment made it possible to study a population-wide sleep gain, thus providing evidence for a potential effective public health intervention.

An earlier version of this winning paper first appeared in our Asia Health Policy Program’s working paper series. The series is open to scholars and health policy experts from around the world and disseminates their papers to a broad international audience through the Program’s website and scholar network and in collaboration with the Social Science Research Network. The Asia Health Policy Program sponsors and manages the Asia health policy postdoctoral fellowship at APARC. Each year, it offers a fellowship position to a recent doctoral graduate.

Read More

People queue while wearing face masks
Blogs

COVID-19 in the Philippines – at a Glance

Marjorie Pajaron, assistant professor at the University of the Philippines School of Economics, describes the unfolding of the pandemic in the country and how Filipinos have coped with the evolving situation.
COVID-19 in the Philippines – at a Glance
A coronavirus spinning with Mongolia flag behind
Blogs

Lessons from Mongolia’s COVID-19 Containment Strategy

Dr. Gendengarjaa Baigalimaa, an oncologist at a hospital in Mongolia’s capital and former postdoctoral fellow with APARC’s Asia Health Policy Program, explains how decisive preventative measures have helped the country prevail in the fight against COVID-19.
Lessons from Mongolia’s COVID-19 Containment Strategy
Karen Eggleston speaking to an online panel.
News

Karen Eggleston Testifies on China’s Healthcare System to Congressional Review Commission

Asia health policy expert Karen Eggleston provides testimony for a U.S.-China Economic and Security Review Commission hearing on China's domestic healthcare infrastructure and the use of technology in its healthcare system amid COVID-19.
Karen Eggleston Testifies on China’s Healthcare System to Congressional Review Commission
Hero Image
Portrait of Young Kyung Do, Winner of the 2020 Rothman Epidemiology Prize
All News button
1
Subtitle

Dr. Young Kyung Do, an expert in health policy and management at the Seoul National University College of Healthy Policy and the inaugural postdoctoral fellow in Asia health policy at APARC, has been awarded the 2020 prize for his outstanding publication in the journal Epidemiology last year.

Authors
Beth Duff-Brown
News Type
News
Date
Paragraphs

Owning a handgun is associated with a dramatically elevated risk of suicide, according to new Stanford research that followed 26 million California residents over a 12-year period. The higher suicide risk was driven by higher rates of suicide by firearm, the study found.

Men who owned handguns were eight times more likely than men who didn’t to die of self-inflicted gunshot wounds. Women who owned handguns were more than 35 times more likely than women who didn't to kill themselves with a gun.

While prior studies have found higher rates of suicide among people who live in homes with a gun, these studies have been relatively small in scale and the risk estimates have varied. The Stanford study is the largest to date, and it’s the first to track risks from the day of an owner’s first handgun acquisition.

“Our findings confirm what virtually every study that has investigated this question over the last 30 years has concluded: Ready access to a gun is a major risk factor for suicide,” said the study’s lead author, David Studdert, LLB, ScD, MPH, professor of medicine at Stanford Health Policy and of law at Stanford Law School.

The study published in The New England Journal of Medicine analyzed data on handgun acquisitions and deaths in a cohort of 26.3 million adult residents of California who had not previously owned handguns. The researchers followed the cohort from 2004 through 2016, and compared death rates among those who did and didn’t acquire handguns, with a particular focus on suicides by firearm versus other methods.

More than 1.4 million cohort members died during the study period. Nearly 18,000 of them died by suicide, of which 6,691 were suicides by firearms.

Often Impulsive Acts

“Suicide attempts are often impulsive acts, driven by transient life crises,” the authors write. “Most attempts are not fatal, and most people who attempt suicide do not go on to die in a future suicide. Whether a suicide attempt is fatal depends heavily on the lethality of the method used — and firearms are extremely lethal. These facts focus attention on firearm access as a risk factor for suicide especially in the United States, which has a higher prevalence of civilian-owned firearms than any other country and one of the highest rates of suicide by firearm.”

There were 24,432 gun suicides in the United States in 2018, according to the Centers for Disease Control and Prevention. Three-quarters of them involved handguns. 

Handgun ownership may pose an especially high risk of suicide for women because of the pairing of their higher propensity to attempt suicide with access to and familiarity with an extremely lethal method.
Yifan Zhang, PhD
PhD, SHP biostatistician

The Stanford study took advantage of the unusually comprehensive body of information on firearm sales in California. All lawful gun purchases and transfers must be transacted through a licensed firearms dealer, who then relays the information to the state’s Department of Justice, where it is archived. The research team obtained records of all firearm acquisitions dating back to 1985, then linked them to death records. 

The researchers found that people who owned handguns had rates of suicide that were nearly four times higher than people living in the same neighborhood who did not own handguns. The elevated risk was driven by higher rates of suicide by firearm. Handgun owners did not have higher rates of suicide by other methods or higher rates of death generally.

The researchers said the very high risk of suicide for female handgun owners, relative to female nonowners, was particularly noteworthy. It has long been known that women attempt suicide more frequently than men but have fewer completed suicides. The standard explanation is that the methods women tend to use are less lethal than those men tend to use. However, the study showed that this is not true for female gun owners.

“Women in our cohort who owned guns and died by suicide usually used a gun,” said Yifan Zhang, PhD, a biostatistician at Stanford Health Policy and co-author of the study. “Handgun ownership may pose an especially high risk of suicide for women because of the pairing of their higher propensity to attempt suicide with access to and familiarity with an extremely lethal method.”

Image
gettyimages sad woman 1160177833

Disentangling Competing Explanations

One major challenge with studies examining the relationship between gun access and suicide risk has been determining whether people who purchase handguns already have plans in place to harm themselves, or whether the presence of a handgun creates new risks.

The unique, longitudinal nature of the Stanford study helped to disentangle these competing explanations.

“There appears to be some of both happening,” said senior author Matthew Miller, professor of health sciences and epidemiology at Northeastern University. “New handgun buyers had extremely high risks of dying by firearm suicide immediately after the purchase. However, more than half of all firearm suicides in this group occurred a year or more later. Consistent with prior work, our findings indicate that gun access poses a substantial and enduring risk.” 

Other Stanford co-authors of the study are research analyst Lea Prince, PhD, and research assistant Erin Holsinger, MD — both at Stanford Health Policy; and Jonathan Rodden, PhD, professor of political science.

Researchers at Erasmus University, in the Netherlands, and the University of Melbourne, in Australia, also contributed to the work.

The research was supported by the Fund for a Safer Future and the Joyce Foundation, as well as Stanford Law School and the Stanford University School of Medicine.

David Studdert

David Studdert

Professor of Medicine and Law
Studdert is an expert in health law and empirical legal research.

Read More

gettyimages gun illustration
News

Mass Shootings: Public Face of a Much Larger Epidemic

Mass Shootings: Public Face of a Much Larger Epidemic
getty images bullets
Commentary

A billion guns worldwide lead to public health burden of homicides and suicides, particularly in United States

A billion guns worldwide lead to public health burden of homicides and suicides, particularly in United States
gettyimages bullets
Blogs

Research into impact of gun violence on public health highlighted as issue becomes part of national dialogue

Research into impact of gun violence on public health highlighted as issue becomes part of national dialogue
Hero Image
gettyimages run illustration Getty Images
All News button
1
Subtitle

Men who own handguns are eight times more likely to die of suicide by handgun than men who don’t have one — and women who own handguns are 35 times more likely than women who don’t, according to startling new research led by SHP's David Studdert.

Authors
News Type
Blogs
Date
Paragraphs

Image
Portrait of Marjorie Pajaron
Marjorie Pajaron’s research lies at the intersection of applied microeconomics and health policy, with a focus on gender, health, development, and labor economics. Prior to her appointment at the University of the Philippines School of Economics, she was a postdoctoral fellow in Asia health policy at APARC.

This is the third installment in our series, “Stories in a Time of Pandemic,” in which APARC alumni across Asia share their perspectives on the responses to and implications of COVID-19 in their communities. In part 1 and part 2 of the series, we feature observations from our alumni in China, Mongolia, Myanmar, and Singapore.


The first case of COVID-19 in the Philippines was reported on January 30, 2020, and local transmission was confirmed on March 7, 2020. As of May 21, the number of cases of COVID-19 has risen to 13,434 and the number of deaths attributed to the virus increased to 846, according to the Philippine Department of Health COVID-19 Case Tracker. It is quite alarming that among the ASEAN countries, the Philippines had the second-highest mortality due to COVID-19, next to Indonesia (as per May 5 date by the WHO COVID-19 Dashboard). This could be attributed to several factors, including whether the country’s health system can handle the overwhelming demand for health care due to the COVID-19 crisis and how effective the government’s response is in stemming the spread of this new pathogen. Inherent in the death statistics is the capacity of a country to conduct COVID-19 tests, which means that there should be a sufficient number of test kits available and that the health workers are properly trained to conduct the tests, trace the contacts, and isolate identified individuals.

The President of the Philippines imposed a total lockdown called enhanced community quarantine (ECQ) for the entire island of Luzon, which encompasses eight administrative regions, including the national capital region, from March 15 to April 30. Other parts of the country have also been under some degree of quarantine at different periods since the appearance of local transmission. Executive Order 112, signed on April 30, 2020, was issued to further extend the ECQ in identified high-risk areas and a general community quarantine (GCQ) in the rest of the country. The inter-agency task force for the management of emerging infectious diseases defines ECQ as the implementation of temporary restrictions on the mobility of people, strict regulations of industries, and a heightened presence of uniformed personnel. GCQ is, in a nutshell, a less strict version of ECQ.

Image
A table showing COVID-19 cases in Southeast Asian countries compared with U.S., China, and total global case count
Image captured from the Center for Strategic and International Studies, Southeast Asia COVID-19 Tracker, May 21, 2020.


The Philippines has faced a lot of challenges during this crisis. First, the health system lacks adequate surge capacity to safely handle a nationwide outbreak of COVID-19 due to shortages of personal protective equipment (PPE), mechanical ventilators, and hospitals with ICUs and isolation beds (see this World Bank report and this Rappler article). More importantly, the insufficient number of health workers, especially in areas outside the metropolitan, is a major concern. Nonetheless, the Department of Health has worked hard to meet the surge in demand due to COVID-19, including partnering with the private sector to repurpose structures and providing data to the public to ensure transparency and accountability. As in other countries, the health workers and those with frontline responsibilities have truly been the new heroes or “bayani” with their tireless efforts and sacrifices. 

A significant challenge pertains to the adverse economic impact of COVID-19. The Philippines has a relatively large informal sector and the income of many families depends on daily transactions with no formal job or social security.
Marjorie Pajaron

Another challenge pertains to the adverse economic impact of COVID-19. The Philippines has a relatively large informal sector and the income of many families depends on daily transactions with no formal job or social security. This has prompted the government to extend cash or in-kind support to vulnerable populations – a response that has posed several challenges, particularly related to the who/what/how framework. First, the Philippine government had to properly identify those in need (who). Second, it had to ensure that sufficient resources can be allocated to the identified groups (what). And third, it had to distribute aid in an efficient, timely, and equitable way (how). The government's social welfare efforts to provide for the vulnerable groups have mixed results: at times, the distribution of aid is organized and efficient, at other times insufficient and disorderly (see these CNN Philippines reports of April 7 and April 30).

COVID-19 in the Philippines – How Filipinos Have Coped

There has been a strong spirit of “bayanihan” or collectivism in the country amidst the COVID-19 crisis. People are volunteering, distributing goods to vulnerable groups, or donating PPE to those with frontline duties. Some enterprises also rose to the occasion by repurposing their businesses to meet the local demand for medical products and PPE.

Different individuals have coped differently: some have welcomed the work hiatus that the quarantine has afforded them, some connected more with friends and family, others become more productive working from home. Staying healthy and being mindful are also factors that contribute to remaining calm and rational in this time of national distress.

Despite the challenges, we will continue to face, especially once the quarantine has eased and the new normal is in effect, we can say that Filipinos have also learned some valuable lessons amid this crisis. For one, Filipinos have become more mindful of the importance of good sanitation and non-pharmaceutical public health measures in mitigating the transmission of the virus. Most Filipinos have also become more proactive in their approach, keeping social distance, wearing masks, and practicing proper handwashing, among others. Furthermore, this crisis has redefined and created new heroes who rose to the challenge – from those staying at home to avoid the further spread of the virus to those on the frontline who have dedicated their time and effort to combat the pandemic, to government and business leaders who have served the country sincerely during this crisis.

Perhaps there really is a silver lining in every cloud.

Read More

A coronavirus spinning with Mongolia flag behind
Blogs

Lessons from Mongolia’s COVID-19 Containment Strategy

Dr. Gendengarjaa Baigalimaa, an oncologist at a hospital in Mongolia’s capital and former postdoctoral fellow with APARC’s Asia Health Policy Program, explains how decisive preventative measures have helped the country prevail in the fight against COVID-19.
Lessons from Mongolia’s COVID-19 Containment Strategy
Various buildings and structures from across Asia
Blogs

Stories in a Time of Pandemic: APARC Alumni Share Their Experiences

We've asked some of our former scholars how COVID-19 is changing life in the many places around the world they call home.
Stories in a Time of Pandemic: APARC Alumni Share Their Experiences
Hero Image
People queue while wearing face masks
Residents queue while wearing face masks before undergoing rapid antibody testing for COVID-19 in Quezon city, Metro Manila, Philippines, May 20, 2020.
Ezra Acayan/ Getty Images
All News button
1
Subtitle

Marjorie Pajaron, assistant professor at the University of the Philippines School of Economics, describes the unfolding of the pandemic in the country and how Filipinos have coped with the evolving situation.

Authors
Noa Ronkin
News Type
News
Date
Paragraphs

Rapid population aging is transforming societies around the world, and the Asia-Pacific region is on the frontlines of this unprecedented demographic shift. Life expectancy in Japan, South Korea, and much of urban China has now outpaced that of the United States and other high-income countries. With this triumph of longevity, however, comes a host of health, social, and economic challenges.

Longer lifespans will necessitate working to older ages, “but extending work lives will only be feasible if the added years are healthy ones, and will only be equitable if the least advantaged also benefit from healthy aging,” writes APARC Deputy Director and Asia Health Policy Program Director Karen Eggleston in her new book, Healthy Aging in Asia. “The great blessing of longer lives dims when clouded by pain, disability, and loss of dignity.”

[Listen to our conversation with Eggelston about the book and continue reading below. To receive stories like this directly in your inbox sign up for APARC newsletters]

Shorenstein APARC · Healthy Aging In Asia | Karen Eggleston

Image
Poster featuring the book Healthy Aging in Asia


Societies around the world must reduce disparities in health outcomes and address the older age-associated rise in the burden of noncommunicable diseases (NCDs) such as diabetes, hypertension, and cancer. Indeed, the COVID-19 pandemic has underscored the vulnerability of older adults suffering from NCDs to newly emerging pathogens and the importance of building long-term, resilient health systems.


How are health systems in Asia promoting evidence-based policies for healthy aging? What strategies have they used to prevent NCDs, screen for early disease detection, raise the quality of care, improve medication adherence, reduce unnecessary hospitalizations, and increase “value for money” in health spending?

The concise chapters in Healthy Aging in Asia examine these questions, covering multiple aspects of policy initiatives and economic research on healthy longevity in diverse Asian economies — from cities such as Singapore and Hong Kong to powerhouses such as Japan, India, and China — as they transform their health systems to support wellbeing in older age. Eggleston edited and contributed multiple chapters to this new volume, now available via Brookings Institution Press. This publication is part of APARC’s in-house series with the Brookings Institution.

Dr. Karen Eggleston

Karen Eggleston

Senior Fellow at the Freeman Spogli Institute for International Studies, Director of the Asia Health Policy Program, and Deputy Director of the Shorenstein Asia-Pacific Research Center
Full Biography

Read More

Karen Eggleston speaking to an online panel.
News

Karen Eggleston Testifies on China’s Healthcare System to Congressional Review Commission

Asia health policy expert Karen Eggleston provides testimony for a U.S.-China Economic and Security Review Commission hearing on China's domestic healthcare infrastructure and the use of technology in its healthcare system amid COVID-19.
Karen Eggleston Testifies on China’s Healthcare System to Congressional Review Commission
Elderly Chinese citizens sit together on a park bench.
Q&As

Karen Eggleston Examines China’s Looming Demographic Crisis, in Fateful Decisions

Karen Eggleston Examines China’s Looming Demographic Crisis, in Fateful Decisions
Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
All News button
1
Subtitle

Asia health policy expert Karen Eggleston’s new volume, ‘Healthy Aging in Asia,’ examines how diverse Asian economies – from Singapore and Hong Kong to Japan, India, and China – are preparing for older population age structures and transforming health systems to support patients who will live with chronic disease for decades.

Authors
Noa Ronkin
News Type
News
Date
Paragraphs

What are the Chinese government’s objectives for the development of its healthcare system? How do these ambitions affect its interaction with U.S. and other foreign healthcare markets? And what policy recommendations should lawmakers consider regarding the development of China's healthcare system and its implications for U.S. national interests? These are some of the questions that APARC Deputy Director and Asia Health Policy Program Director Karen Eggleston discussed in her testimony before the U.S.-China Economic and Security Review Commission on May 7, 2020.

Watch Eggleston’s testimony (start time 23:25]

Read Eggleston's complete testimony
Download pdf

[To receive more stories like this in your inbox sign up for APARC’s newsletters]

Chaired by Dr. Robin Cleveland, the commission’s hearing, “China’s Evolving Healthcare Ecosystem: Challenges and Opportunities,” focused on China's domestic healthcare infrastructure and its use of technology in the light of the COVID-19 pandemic. The commission listened as Eggleston reviewed the strides China has made in its national health reforms and highlighted the many challenges its health system now faces. “It is in the interest of Americans and Chinese to have a strong, resilient healthcare system in China,” she said. “The United States should reemphasize scientific, evidence-based health policy and regulation, and encourage China to do so as well.”

The commission’s mandate is to investigate and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and China and to provide recommendations to Congress for legislative action.

Ambitious Goals, Complex Challenges

Reforms over the past two decades, noted Eggleston, have brought China’s health system closer to a level of reliability and accessibility commensurate with the country’s dramatic economic growth. The government has already achieved its goal of providing universal health coverage and has made significant progress in many of the areas outlined in its “Healthy China 2030” blueprint, including tackling health disparities between regional and urban/rural population subgroups and building a more comprehensive and higher quality health service delivery system.

Still, China faces many daunting challenges, from dealing with COVID-19 and its aftermath to other urgent and lingering needs, such as tackling its looming demographic crisis and promoting healthy aging, addressing patient-provider tensions and trust, and changing provider payment to promote “value” rather than volume. If China is to make its investments in universal health coverage and rapid medical spending growth sustainable, said Eggleston, then it must build an infrastructure that increases health system efficiency, strengthens primary care, reforms provider payment system, and protects the most vulnerable from illness-induced poverty.

Constructive policies in support of health system improvements in both the United States and China could strengthen the global capacity to control future pandemics and avoid the devastating social and economic effects of future outbreaks on the scale of COVID-19.
Karen Eggleston

Technology and COVID-19 Response

Like other countries, China’s government and private sector have utilized various technologies in response to the COVID-19 crisis, such as telemedicine, “internet-plus” healthcare, and contact tracing applications, and are deploying digital and biotechnologies in efforts focused on epidemic mentoring and on treatment and vaccine development. Eggleston noted that the response to COVID-19 “will leave an indelible mark on health policies for decades to come,” not only in terms of technology adoption but also organizational innovation. One would hope to see future prioritization in resource allocation and renewed investment in the diagnosis and treatment of health system weaknesses, she added.

Recommendations for Congress

In all our policies and interactions, Eggleston concluded her testimony, we should remember that China is large and diverse, that local government agencies are those that make many important decisions in health policies as in other policies, and that the “Chinese people” are not synonymous with any given leader. “Avoid politicizing the COVID-19 pandemic and other health and humanitarian issues,” she noted. “In other geopolitical considerations in bilateral US-China relations, uphold U.S. interests while encouraging the PRC to be active as a globally responsible stakeholder.”

The U.S. government should encourage China and its scientists and firms to work collaboratively with multilateral efforts to prevent and control future pandemics, she argued. Specific recommended actions include supporting efforts to strengthen primary care and population health interventions with proven cost-effectiveness; sharing experiences with regional, community-based efforts to address the social determinants of health and promote multisector policies for healthy aging; encouraging public-private collaborative governance arrangements to strengthen the health sector in China; promoting transparent peer review of research and international collaboration between Chinese and American scientists, medical educators, health systems researchers, and technology developers; and collaborating with Chinese counterparts to address regional issues of population health importance, such as health problems in the DPRK and integration of public health priorities into China’s Belt and Road Initiative.

Read Eggleston's complete testimony >> 

Read More

Elderly Chinese citizens sit together on a park bench.
Q&As

Karen Eggleston Examines China’s Looming Demographic Crisis, in Fateful Decisions

Karen Eggleston Examines China’s Looming Demographic Crisis, in Fateful Decisions
Young patients receive treatment at Chongqing Children's Hospital in Chongqing Municipality, China.
News

On China’s Dramatic Health Care System Improvements – and Its Tortuous Road Ahead

On China’s Dramatic Health Care System Improvements – and Its Tortuous Road Ahead
Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
Hero Image
Karen Eggleston speaking to an online panel.
All News button
1
Subtitle

Asia health policy expert Karen Eggleston provides testimony for a U.S.-China Economic and Security Review Commission hearing on China's domestic healthcare infrastructure and the use of technology in its healthcare system amid COVID-19.

-

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.

 

To celebrate its May release, contributors Karen Eggleston, Barry Naughton, and Andrew Walder will join editors Thomas Fingar and Jean Oi for a panel discussion of their volume Fateful Decisions: Choices That Will Shape China’s Future (Stanford University Press).  China has enjoyed an extraordinary run of rapid growth and development over the last 40 years.  Yet, as Fingar and Oi point out, China’s future is hardly set in stone.  Sustained economic growth, social welfare and stability will depend upon tough policy decisions confronting Beijing’s leaders today in what is a watershed moment.  Casting doubt on Beijing’s aversion to major reforms and its return to certain Mao-era policy tools, Oi and Fingar argue that China’s challenges are not only complex, but high-stakes – challenges that have become even more daunting in the aftermath of COVID-19.  As China battles the difficulties caused by an aging population, the loss of comparative economic advantage, a politically entrenched elite, and a population with rising expectations, today’s policy decisions will weigh heavily on its future. Topics explored in the volume include China's healthcare challenges in a slowing economy, its global ambitions and track record, economic aims and realities, the country’s mounting governance pressures, and more. 

 

Fateful Decisions is available for purchase here.

 

Fore more information on Fateful Decisions, check out these articles:

Karen Eggleston Examines China’s Looming Demographic Crisis, in Fateful Decisions

Now It Gets Much Harder: Thomas Fingar and Jean Oi Discuss China’s Challenges in The Washington Quarterly

China’s Challenges: Now It Gets Much Harder

 

Portrait of Karen EgglestonKaren Eggleston is a senior fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University, director of the Stanford Asia Health Policy Program, and deputy director of the Walter H. Shorenstein Asia-Pacific Research Center at FSI. She is also a fellow with the Stanford Center for Innovation in Global Health and a faculty research fellow of the National Bureau of Economic Research (NBER). Eggleston earned her PhD in public policy from Harvard University, studied in China for two years, and was a Fulbright scholar in South Korea. Her research focuses on comparative health systems and health reform in Asia, especially China; government and market roles in the health sector; supply-side incentives; healthcare productivity; and economic aspects of demographic change.

 

Portrait of Thomas FingarThomas Fingar is a Shorenstein Distinguished Fellow in the Shorenstein Asia-Pacific Research Center at Stanford University. From May 2005 through December 2008, he served as the first deputy director of national intelligence for analysis and, concurrently, as chairman of the National Intelligence Council. Previous positions include assistant secretary of state for Intelligence and Research (2000-2001, 2004–2005), principal deputy assistant secretary (2001–2003), deputy assistant secretary for analysis (1994–2000), director of the Office of Analysis for East Asia and the Pacific, and chief of the China Division. Fingar is a graduate of Cornell University (AB in government and history) and Stanford University (MA and PhD, both in political science). His most recent books are Uneasy Partnerships: China’s Engagement with Japan, the Koreas, and Russia in the Era of Reform (editor) (Stanford University Press, 2017); The New Great Game: China’s Relations with South and Central Asia in the Era of Reform (editor) (Stanford University Press, 2016); and Reducing Uncertainty: Intelligence Analysis and National Security (Stanford University Press, 2011).

 

Image
Photo of Barry Naughton
Barry Naughton is the So Kwanlok Professor at the School of Global Policy and Strategy, University of California–San Diego. Naughton’s work on the Chinese economy focuses on market transition; industry and technology; foreign trade; and political economy. His first book, Growing Out of the Plan, won the Ohira Prize in 1996, and a new edition of his popular survey and textbook, The Chinese Economy: Adaptation and Growth, appeared in 2018. Naughton did his dissertation research in China in 1982 and received his PhD in economics from Yale University.

 

Jean C. OiJean C. Oi is the William Haas Professor of Chinese Politics in the Department of Political Science and a senior fellow in the Freeman Spogli Institute for International Studies at Stanford University. She directs the China Program at the Walter H. Shorenstein Asia-Pacific Research Center and is the Lee Shau Kee Director of the Stanford Center at Peking University. Oi has published extensively on China’s reforms. Recent books include Zouping Revisited: Adaptive Governance in a Chinese County, coedited with Steven Goldstein (Stanford University Press, 2018), and Challenges in the Process of China’s Urbanization, coedited with Karen Eggleston and Yiming Wang (2017). Current research is on fiscal reform and local government debt, continuing SOE reforms, and the Belt and Road Initiative.

 

Portrait of Andrew WalderAndrew G. Walder is the Denise O’Leary and Kent Thiry Professor of Sociology in the School of Humanities and Sciences, and a senior fellow in the Freeman Spogli Institute for International Studies at Stanford University. A political sociologist, Walder has long specialized in the study of contemporary Chinese society and political economy. After receiving his PhD at the University of Michigan, he taught at Columbia, Harvard, and the Hong Kong University of Science and Technology. At Stanford he has served as chair of the Department of Sociology, director of the Asia-Pacific Research Center, and director of the Division of International, Comparative, and Area Studies in the School of Humanities and Sciences. His most recent books are Fractured Rebellion: The Beijing Red Guard Movement (2009), China under Mao: A Revolution Derailed (2015), and Agents of Disorder: Inside China’s Cultural Revolution (2019).

Via Zoom Webinar.
Register at: https://bit.ly/2WiwPvm

Karen Eggleston <br> Senior Fellow at FSI; Director of the Asia Health Policy Program, Shorenstein APARC, Stanford University <br><br>
Thomas Fingar <br> Shorenstein APARC Fellow, Stanford University <br><br>
Barry Naughton <br> Sokwanlok Chair of Chinese International Affairs, School of Global Policy and Strategy, UC San Diego <br><br>
Jean C. Oi <br> Director, Stanford China Program; William Haas Professor of Chinese Politics, Stanford University <br><br>
Andrew Walder <br> Senior Fellow at FSI; Denise O'Leary and Kent Thiry Professor, Stanford University <br><br>
Panel Discussions
Paragraphs
Cover of Healthy Aging in Asia that shows an elderly woman in a Chinese village.
Life expectancy in Japan, South Korea, and much of urban China has now outpaced that of the United States and other high-income countries. With this triumph of longevity, however, comes a rise in the burden of noncommunicable diseases (NCDs) like diabetes and hypertension, reducing healthy life years for individuals in these aging populations, as well as challenging the healthcare systems they rely on for appropriate care.  
 
The challenges and disparities are even more pressing in low- and middle-income economies, such as rural China and India. Moreover, the COVID-19 pandemic has underscored the vulnerability to newly emerging pathogens of older adults suffering from NCDs, and the importance of building long-term, resilient health systems. 
 
What strategies have been tried to prevent NCDs—the primary cause of morbidity and mortality — as well as to screen for early detection, raise the quality of care, improve medication adherence, reduce unnecessary hospitalizations and increase “value for money” in health spending? 
 
Fourteen concise chapters cover multiple aspects of policy initiatives for healthy aging and economic research on chronic disease control in diverse health systems — from cities such as Singapore and Hong Kong to large economies such as Japan, India, and China. 
 

Desk, examination, or review copies can be requested through Stanford University Press.

All Publications button
1
Publication Type
Books
Publication Date
Authors
Karen Eggleston
Book Publisher
Shorenstein APARC
News Type
News
Date
Paragraphs

While Wuhan, China was the first epicenter of the COVID-19 pandemic, every nation in Asia has been deeply affected by the spread of the virus. In a virtual seminar convened by the Freeman Spogli Institute, APARC experts discuss the social and economic impacts of COVID-19 and the various policy responses to the pandemic across Asian nations.

Senior Fellow Xueguang Zhou focuses on the phases of crisis response taken by the PRC in the early stages of the unfolding coronavirus outbreak. Center Fellow and Korea Program Deputy Director Yong Suk Lee discusses the policy responses of the South Korean government. Southeast Asia Program Director Don Emmerson offers a comparison of different governance strategies and actions implemented across Southeast Asian countries, while Karen Eggelston, APARC's deputy director and director of the Asia Health Policy Program, addresses the response of health systems in Japan and South Asia.

Watch the full discussion and Q&A below. You can also read the Stanford Daily's coverage of the event.

Read More

An empty Pennsylvania Avenue in Washington, D.C. seen with the United States Capitol  in the background.
News

APARC Fellow Thomas Fingar on the U.S. Intelligence Report that Warned of a Coronavirus Pandemic

In our online conversation, Fingar discusses the 2008 National Intelligence Council report he oversaw and that urged action on coronavirus pandemic preparedness, explains the U.S. initial failed response to the COVID-19 outbreak, and considers the implications of the current crisis for U.S.-China relations.
APARC Fellow Thomas Fingar on the U.S. Intelligence Report that Warned of a Coronavirus Pandemic
BEIJING, CHINA - Workers sit near a CRH (China Railway High-speed) "bullet train" at the Beijing South Railway Station under reconstruction.
News

High-Speed Rail Holds Promise and Problems for China, Explains David M. Lampton

In a new audio interview, Lampton discusses some of the challenges, uncertainties, and decisions that loom ahead of China's Belt and Road Initiative.
High-Speed Rail Holds Promise and Problems for China, Explains David M. Lampton
Portrait of Tom Wright, winner of the 2020 Shoresntein Journalism Award
News

Tom Wright, Coauthor of Bestseller 'Billion Dollar Whale' and Longtime Asia Reporter, Wins 2020 Shorenstein Journalism Award

Tom Wright, Coauthor of Bestseller 'Billion Dollar Whale' and Longtime Asia Reporter, Wins 2020 Shorenstein Journalism Award
Hero Image
Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
All News button
1
Subtitle

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.

Authors
Beth Duff-Brown
News Type
News
Date
Paragraphs

Most of the stillbirths that occur around the world are among women who live in low- and middle-income countries. Some 2.5 million women suffer the heartbreaking loss each year.

Yet determining the causes and prevention of stillbirths has largely been ignored as a global health priority — the incidence not even included in the WHO Millennium Development Goals.

Stanford Health Policy’s Rosenkranz Prize Winner, Ashley Styczynski, MD, MPH, discovered the alarmingly high level of stillbirths while working in Bangladesh as a 2019-2020 Fogarty Fellow, studying antimicrobial resistance in newborns in the hospitals there.

The $100,000 Rosenkranz Prize is awarded to a Stanford researcher who is doing innovative work to improve health in the developing world.

“I was surprised to learn that the rates of stillbirths were comparable to sub-Saharan Africa and that in many cases they had no idea of the cause,” Styczynski said in a Skype call from Dhaka, where she has been living for eight months while conducting her antimicrobial resistance research.

specimen collection1 copy Rosenkranz Prize Winner Ashley Styczynski takes specimen samples with women in Dhaka, Bangladesh, for her research on antimicrobial resistance in newborns. This research led to her prize-winning proposal to investigate the alarmingly high rate of stillbirths in the South Asian nation.

The South Asian nation is among the top 10 countries with the highest number of stillbirths, with an average of 25.4 stillbirths per 1,000 births. Studies have implicated maternal infections as the cause; one ongoing study in Bangladesh has recovered bacteria from blood samples in stillborn babies in whom no prior maternal infection was suspected.

Styczynski believes intrauterine infections may be an underrecognized factor contributing to the excess stillbirths in Bangladesh. She intends to perform metagenomic sequencing on placental tissues of stillborn babies, a process that will allow her to examine the genes in the organisms of those tissues and evaluate the bacterial diversity.

“The alternative hypothesis would be that stillbirths are caused by non-infectious etiologies, which I will be assessing through interviews,” Styczynski wrote in her Rosenkranz application.

Those interviews will be with mothers to evaluate for frequency of infectious symptoms during pregnancy, including fever, rash, cough, dysuria and diarrhea, as well as possible toxin exposures. She will compare the findings with the metagenomic sequencing results to determine how frequently potential pathogens may be presenting as subclinical infections.

My goal is to reduce excess stillbirths by identifying risk factors and pathogens that may be contributing to stillbirths and, ultimately, to design prevention strategies.
Ashley Styczynski
Rosenkranz Prize Winner

“By applying advanced technologies and software platforms, this research will not only enhance our understanding of causes of stillbirths in Bangladesh, but it may also provide insights into causes of early neonatal deaths," Styczynski said.

Bangladesh, one of the poorest and most densely populated nations in the world, offers a rich variety of emerging and known diseases that go undetected.

“The panoply of infections that could contribute to stillbirths is really unknown,” Styczynski said. “That’s why metagenomics is a great tool here. It just hasn’t been accessible here because of the expense. Now this tool will begin to unpack what’s causing these stillbirths.”

The Rosenkranz Prize was started and endowed by the family of the late Dr. George Rosenkranz, who devoted his career to improving health-care access across the world and helped synthesize the active ingredient for the first oral birth control pill.

“No one is more deserving of the Rosenkranz Prize than Dr. Ashley Styczynski”, said Dr. Ricardo Rosenkranz. “Because of her tenacity, originality and focus, Dr. Styczynski exemplifies the ideal Rosenkranz Prize recipient. She has chosen an often overlooked adverse outcome that may prove to be mitigated by her findings. As a neonatologist interested in health disparities, I fully realize the potential relevance and urgency of her work and am excited to see it come to fruition. As the son of George Rosenkranz, for whom this prize is lovingly named, I know that my father would appreciate Dr. Styczynski’s pioneering spirit as well as her desire to affect global positive change by improving medical outcomes in vulnerable communities. We can’t wait to celebrate her work back at Stanford in the near future."

Sheltering in Place

Styczynski spoke from her flat in Dhaka, where she has been confined for three weeks as the world’s third-most populated city prepares for the onslaught of the coronavirus. The country is on lockdown; no international flights in or out.

As of Thursday, there were 1,572 cases in Bangladesh and 60 deaths, according to the widely used Johns Hopkins Coronavirus Map.

But Styczynski believes that’s about 1% of the actual disease activity in the country because testing was so slow to start. She said there is great stigma in the country over testing — red flags are put on the homes of those who have been diagnosed with COVID-19 — because it breaks up the unity of families and the surrounding community. Health-care workers are being kicked out of apartments by frightened landlords and people are afraid to use the health-care system for fear of infection.

“So, the hospitals are quite empty — more so than they’ve ever been,” she said.

Styczynski likened it to waiting for the tsunami that you know is coming.

“That’s why I wanted to jump in to stave off the morbidity and mortality that will be inundating one of the most populated countries in the world,” she said. Some 165 million people are packed into 50,250 square miles — a land mass about the same size as New York State, which has some 19.5 million people.

triage at upazila health complex1 copy Ashley Styczynski goes through a thermoscanner was when I was testing out the triage system at an upazila health complex.

The Centers for Disease Control and Prevention (CDC) has a small team of four people working in Bangladesh. Having spent two years as an Epidemic Intelligence Service Officer at the CDC, Styczynski has now joined its Bangladesh team and is also working with the infection prevention and control team of the International Centre for Diarrhoeal Disease Research, Bangladesh.

“Many people here in Dhaka live in high-density apartments with six to 12 people living in the same room,” she said. “How do you isolate when you have a one-room home?”

Ninety percent of the population are daily wage earners, Styczynski noted, who say they’d rather take their chances with coronavirus than die of starvation.

They take those chances at great risk. There is one ventilator for every 100,000 people in Bangladesh and the district hospitals have maybe one to two days of oxygen supply, Styczynski said.

They started out training military hospitals on medical triage, quarantine and isolation, and infection prevention strategies.

“We’ve also been going to some district hospitals to assess some of the challenges they are facing and to identify some of the gaps in preparedness so that we can communicate back to the Ministry of Health how they can better support these district hospitals,” she said.

Her pandemic travels to the district hospitals and preparedness work has allowed her to gather contextual data for her colleagues back at Stanford who are working to address the lack of personal protective equipment (PPE) in low-resourced countries.

“We hope we can generate some evidence very quickly so that we can share some of this information to better protect health-care workers in other low-resource countries,” she said.

Despite her research being temporarily sidelined, Styczynski is upbeat.

“This is what I signed up for as a Fogarty fellow, to help build local capacity,” she said. “But I am also an infectious disease specialist, and these are the types of situations we run towards rather than away from. We build our career for moments like these.”

Read More

ami ricky
News

Rosenkranz Prize winner to launch microbiome research project in Africa

Rosenkranz Prize winner to launch microbiome research project in Africa
kenya rosenkranz6
News

Rosenkranz Prize winner brings statistics to rape prevention in Kenya

Rosenkranz Prize winner brings statistics to rape prevention in Kenya
Prasanna Jagannathan Rosenkranz
News

Rosenkranz Prize Winner Hopes to Develop Malaria Vaccine Targeting Pregnant Women

Prasanna Jagannathan and his lab members intend to ramp up their research in Uganda. A member of the nonprofit Infectious Disease Research Collaboration in Kampala, his team is particularly interested in how strategies that prevent malaria might actually alter the development of natural immunity to malaria.
Rosenkranz Prize Winner Hopes to Develop Malaria Vaccine Targeting Pregnant Women
Hero Image
evaluating ventilator
Ashley Styczynski (center) evaluating the set-up in one military hospital in Dhaka in preparation for COVID patients. There is only one ventilator available for every 100,000 people in the South Asian nation.
Ashley Styczynski
All News button
1
Subtitle

Stanford postdoc Ashley Styczynski will investigate the epidemiology behind the alarmingly high rate of stillbirths in Bangladesh while helping prepare for the coming onslaught of coronavirus in the densely populated South Asian nation.

Subscribe to Health policy